Back to top
07971459383
Send SMS    Call Me Free Send Inquiry


Recombinant Tissue Plasminogen Activator For Injection 20 Mg Kit
Recombinant Tissue Plasminogen Activator For Injection 20 Mg Kit

Recombinant Tissue Plasminogen Activator For Injection 20 Mg Kit

Price 25500 INR/ Unit

MOQ : 1 Unit

Recombinant Tissue Plasminogen Activator For Injection 20 Mg Kit Specification

  • Dosage Form
  • Injection
  • Indication
  • Acute ischemic stroke
  • Brand Name
  • Gennova
  • Packaging Type
  • Vial
  • Pacakaging (Quantity Per Box)
  • Single vial kit
  • Salt Composition
  • Recombinant Tissue Plasminogen Activator
  • Life Span
  • Check pack for expiry
  • Origin of Medicine
  • India
  • Drug Type
  • Prescription Biologic
  • Ingredients
  • Recombinant Tissue Plasminogen Activator
  • Physical Form
  • Injection
  • Function
  • Clot dissolving agent
  • Recommended For
  • Ischemic stroke (emergency use)
  • Dosage
  • 20 mg
  • Dosage Guidelines
  • As prescribed by physician
  • Suitable For
  • Adults (as directed)
  • Quantity
  • 20 mg per vial
  • Storage Instructions
  • Store below 25C
  • Manufactured By
  • Gennova
  • Prescription Status
  • Rx only
  • Administration Route
  • Intravenous
  • Therapeutic Class
  • Thrombolytic agent
  • Sterility
  • Sterile
  • Kit Components
  • Powder & solvent vial
  • Shelf Life
  • Provided on packaging
  • Reconstitution Required
  • Yes
  • Color
  • White to off-white powder
 

Recombinant Tissue Plasminogen Activator For Injection 20 Mg Kit Trade Information

  • Minimum Order Quantity
  • 1 Unit
  • Payment Terms
  • Cash in Advance (CID)
  • Supply Ability
  • 1000 Units Per Month
  • Delivery Time
  • 7 Days
  • Main Domestic Market
  • All India
 

About Recombinant Tissue Plasminogen Activator For Injection 20 Mg Kit



Discover the ephemeral, exclusive deal on the Gennova Recombinant Tissue Plasminogen Activator For Injection 20 mg Kit-an optimum choice in premier thrombolytic therapy. Featuring classic innovation, this sterile kit includes a white to off-white powder with solvent for precise intravenous administration. Formulated for emergency use in adults with acute ischemic stroke, it delivers reliable clot-dissolving action. The kit's single vial ensures proper dosage as prescribed. Manufactured in India, it complies with the highest prescription biologic standards for efficacy and safety.

Distinctive Features & Commercial Value

Recombinant Tissue Plasminogen Activator For Injection 20 mg Kit stands out for its commercial significance in emergency departments and stroke centers. The kit features both powder and solvent vials, ensuring ease of reconstitution and accurate dosing. Its classic material composition delivers optimum outcomes in acute ischemic stroke management. With exclusive formulation by Gennova, this product supports critical care with sterile, high-purity Recombinant Tissue Plasminogen Activator, enhancing patient recovery in time-sensitive scenarios.


Domestic Market Reach & Supply Details

Gennova's premier clot-dissolving injection holds a substantial charge across the domestic mar, ensuring swift shipment and availability. Each kit is packed in a secure single vial packaging type, accompanied by all reconstitution materials for authorized use. Supply ability is robust and meets urgent commercial demand, supporting national healthcare providers with on-time, temperature-controlled shipments for reliable patient intervention.


FAQ's of Recombinant Tissue Plasminogen Activator For Injection 20 Mg Kit:


Q: How should the Recombinant Tissue Plasminogen Activator For Injection 20 mg Kit be administered?

A: This kit is intended for intravenous administration only. Proper reconstitution by a healthcare professional is required before use. Dosage should be determined by the prescribing physician.

Q: What are the commercial uses of this thrombolytic agent?

A: It is primarily used in hospitals and stroke centers for the emergency treatment of adults experiencing acute ischemic stroke to dissolve clots rapidly and restore blood flow.

Q: When is this product indicated for use?

A: The kit is indicated for adults during acute ischemic stroke emergencies, allowing timely intervention to minimize neurological damage.

Q: Where should this injection be stored before use?

A: Store the product below 25C and refer to the package for precise shelf life and expiration information to ensure efficacy and safety.

Q: What makes this kit a premier choice among thrombolytic agents?

A: Its sterile, high-quality recombinant formulation and exclusive single-vial design enable accurate dosing and ease of use, supporting optimum outcomes in critical care environments.

Q: What is the process for preparing and administering the product?

A: A trained medical professional will reconstitute the powder with the provided solvent vial, then administer the solution intravenously under prescription guidelines.